Transport mechanisms of a novel antileukemic and antiviral compound 9-norbornyl-6-chloropurine

References

• Šála M, De Palma AM, Hřebabecký H, et al. SAR studies of 9-norbornylpurines as Coxsackievirus B3 inhibitors. Bioorg Med Chem Lett 2011;21:4271–5
   PubMed Web of Science ®Google Scholar
• Šála M, Hřebabecký H, Leyssen P, et al. Novel substituted 9-norbornylpurines and their activities against RNA viruses. Bioorg Med Chem Lett 2012;22:1963–8
   PubMed Web of Science ®Google Scholar
• Senior K. FDA panel rejects common cold treatment. Lancet Infect Dis 2002;2:264
   PubMed Web of Science ®Google Scholar
• DeLong DC, Reed SE. Inhibition of rhinovirus replication in organ culture by a potential antiviral drug. J Infect Dis 1980;141:87–91
   PubMed Web of Science ®Google Scholar
• Plačková P, Rozumová N, Hřebabecký H, et al. 9-Norbornyl-6-chloropurine is a novel antileukemic compound interacting with cellular GSH. Anticancer Res 2013;33:3163–8
   PubMed Web of Science ®Google Scholar
• Chang C, Swaan PW, Ngo LY, et al. Molecular requirements of the human nucleoside transporters hCNT1, hCNT2, and hENT1. Mol Pharmacol 2004;65:558–70
   PubMed Web of Science ®Google Scholar
• Griffith DA, Jarvis SM. Nucleoside and nucleobase transport systems of mammalian cells. Biochim Biophys Acta 1996;1286:153–81
   PubMed Web of Science ®Google Scholar
• Pérez-Torras S, Vidal-Pla A, Cano-Soldado P, et al. Concentrative nucleoside transporter 1 (hCNT1) promotes phenotypic changes relevant to tumor biology in a translocation-independent manner. Cell Death Dis 2013;4:e648
   PubMedGoogle Scholar
• Olšanská L, Cihlář T, Votruba I, Holý A. Transport of Adefovir (PMEA) in human T-lymphoblastoid cells. Collect Czech Chem Commun 1997;62:821–8
   Web of Science ®Google Scholar
• Cihlář T, Rosenberg I, Votruba I, Holý A. Transport of 9-(2-phosphonomethoxyethyl)adenine across plasma membrane of HeLa S3 cells is protein mediated. Antimicrob Agents Chemother 1995;39:117–24
   PubMed Web of Science ®Google Scholar
• Šála M, De Palma AM, Hřebabecký H, et al. Design, synthesis, and biological evaluation of novel coxsackievirus B3 inhibitors. Bioorg Med Chem 2010;18:4374–84
   PubMed Web of Science ®Google Scholar
• Okamura T, Kikuchi T, Fukushi K, et al. A novel noninvasive method for assessing glutathione-conjugate efflux systems in the brain. Bioorg Med Chem 2007;15:3127–33
   PubMed Web of Science ®Google Scholar
• O'Dwyer PJ, LaCreta F, Nash S, et al. Phase I study of thiotepa in combination with the glutathione transferase inhibitor ethacrynic acid. Cancer Res 1991;51:6059–65
   PubMed Web of Science ®Google Scholar
• Griffith OW. Mechanism of action, metabolism, and toxicity of buthionine sulfoximine and its higher homologs, potent inhibitors of glutathione synthesis. J Biol Chem 1982;257:13704–12
   PubMed Web of Science ®Google Scholar
• Morales MC, Pérez-Yarza G, Nieto-Rementeria N, et al. Intracellular glutathione levels determine cell sensitivity to apoptosis induced by the antineoplasic agent N-(4-hydroxyphenyl) retinamide. Anticancer Res 2005;25:1945–51
   PubMed Web of Science ®Google Scholar
• Zegers MMP, Zaal KJM, van Ijzendoorn SCD, et al. Actin filaments and microtubules are involved in different membrane traffic pathways that transport sphingolipids to the apical surface of polarized HepG2 cells. Mol Biol Cell 1998;9:1939–49
   PubMed Web of Science ®Google Scholar
• Sandvig K, van Deurs B. Selective modulation of the endocytic uptake of ricin and fluid phase markers without alteration in transferrin endocytosis. J Biol Chem 1990;265:6382–8
   PubMed Web of Science ®Google Scholar
• Damaraju VL, Smith KM, Mowles D, et al. Interaction of fused-pyrimidine nucleoside analogs with human concentrative nucleoside transporters: high-affinity inhibitors of human concentrative nucleoside transporter 1. Biochem Pharmacol 2011;81:82–90
   PubMed Web of Science ®Google Scholar
• Lin DC, Lin S. High affinity binding of [3H]dihydrocytochalasin B to peripheral membrane proteins related to the control of cell shape in the human red cell. J Biol Chem 1978;253:1415–19
   PubMed Web of Science ®Google Scholar
• Dolberg DS, Bassham JA, Bissell MJ. Selective inhibition of the facilitated mode of sugar uptake by cytochalasin B in cultured chick fibroblasts. Exp Cell Res 1975;96:129–37
   PubMed Web of Science ®Google Scholar
• Muir EM, Bowyer DE. Dependence of fluid-phase pinocytosis in arterial smooth-muscle cells on temperature, cellular ATP concentration and the cytoskeletal system. Biochem J 1983;216:467–73
   PubMed Web of Science ®Google Scholar
• Haigler HT, McKanna JA, Cohen S. Rapid stimulation of pinocytosis in human carcinoma cells A-431 by epidermal growth factor. J Cell Biol 1979;83:82–90
   PubMed Web of Science ®Google Scholar
• Mizel SB, Wilson L. Nucleoside transport in mammalian cells. Inhibition by colchicine. Biochemistry 1972;11:2573–8
   PubMed Web of Science ®Google Scholar
• Plagemann PG, Zylka JH, Erbe J, Estensen RD. Membrane effects of cytochalasin B. Competitive inhibition of facilitated diffusion processes in rat hepatoma cells and other cell lines and effect on formation of functional transport sites. J Membr Biol 1975;23:77–90
   PubMed Web of Science ®Google Scholar
• Schmid SL. The mechanism of receptor-mediated endocytosis. More questions than answers. Bioessays 1992;14:589–96
   PubMed Web of Science ®Google Scholar
• Yamada H, Abe T, Li SA, et al. Dynasore, a dynamin inhibitor, suppresses lamellipodia formation and cancer cell invasion by destabilizing actin filaments. Biochem Biophys Res Commun 2009;390:1142–8
   PubMed Web of Science ®Google Scholar